Recent clinical trials have shown promising results for the use of immunotherapy in treating certain types of breast cancer. Particularly effective in triple-negative breast cancer, which lacks targeted treatments, immunotherapy provides a promising alternative. Trials have demonstrated improved survival rates and disease-free periods, heralding a new era in breast cancer care. However, research is ongoing to understand which patients are most likely to benefit.
- Log in or register to contribute
Contribute to three or more articles across any domain to qualify for the Contributor badge. Please check back tomorrow for updates on your progress.